Skip Navigation


BJA Advance Access originally published online on January 22, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/3/424    most recent
aeh070v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Inagawa, G.
Right arrow Articles by Andoh, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inagawa, G.
Right arrow Articles by Andoh, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2004, Vol. 92, No. 3 424-426
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia

Short Communications

Opposite effects of depressant and convulsant barbiturate stereoisomers on acetylcholine release from the rat hippocampus in vivo

G. Inagawa*, K. Sato, T. Kikuchi, M. Nishihama, M. Shioda, Y. Koyama, Y. Yamada and T. Andoh

Department of Anesthesiology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanasawa-Ku, Yokohama 236-0004, Japan

*Corresponding author. E-mail: inagawa@med.yokohama-cu.ac.jp

Background. It has been shown that the R(–) isomer of 1-methyl-5-phenyl-5-propyl barbituric acid (MPPB) induces loss of the righting reflex (LRR), while S(+)-MPPB causes pure excitatory effects, including convulsions, in vivo.

Methods. We studied the effects of the depressant and convulsant MPPB stereoisomers on rat hippocampal acetylcholine (ACh) release in vivo, using a brain microdialysis technique in freely moving animals.

Results. R(–)-MPPB 60 and 90 mg kg–1 i.p. decreased ACh release from the rat hippocampus by 44.1 (8.2)% and 60.8 (8.2)%, respectively. In the hippocampus, the local application of bicuculline, a {gamma}-aminobutyric acid (GABA)A receptor antagonist, 1 µmol litre–1 antagonized the inhibitory effects of R(–)-MPPB 90 mg kg–1 i.p. In contrast, R(–)-MPPB, S(+)-MPPB 60 and 90 mg kg–1 i.p. increased ACh release to 151.8 (6.8)% and 169.6 (11.1)% of the basal release, respectively.

Conclusions. Our results demonstrated that R(–)-MPPB decreased, while S(+)-MPPB increased, rat hippocampal ACh release and that the inhibitory effects of R(–)-MPPB may involve the GABAA receptor in vivo. These data imply that changes in hippocampal ACh due to these agents may be related to their central inhibitory and stimulatory actions in vivo.

Br J Anaesth 2004; 92: 424–6


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.